-

Trinity Life Sciences Accelerates Future with Strategic Brand Transformation and AI-Enabled Solutions

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in life sciences commercialization, today unveiled a sweeping brand transformation that underscores its commitment to innovation, technology, and customer-centric solutions. This next chapter positions Trinity as a strategic, tech-enabled partner empowering pharma, biotech, and medtech companies to accelerate development, optimize commercial launches, and drive measurable impact across the healthcare ecosystem.

The updated brand reflects Trinity’s significant investment over the past 5 years to advance its AI and technology capabilities. More than $100M has been invested by Trinity as part of the company’s commitment to optimize the value clients realize every step of the way, from concept to commercialization.

“Powering the future of life sciences commercialization through the fusion of human and artificial intelligence — that’s the vision that drives our team,” said Trinity CEO, Leslie Orne. “Our bold new brand reflects our strategic commitment to helping clients seize a decisive advantage in an increasingly dynamic marketplace. With AI-driven solutions, and renewed purpose, we are united as innovators and dedicated partners, well-positioned to redefine successful commercialization for the next generation of medical progress and patient outcomes.”

Key highlights of Trinity’s transformation include:

  • New AI capabilities that enable clients to predict launch success, optimize investments, and de-risk portfolios with up to 90% accuracy in predicting the likelihood of success for new therapies.
  • The reinvigoration of TrinityEDGE, an integrated technology platform delivering predictive foresight, integrated execution, and end-to-end commercial solutions, from pre-launch to scale and loss of exclusivity.
  • A modernized brand architecture that elevates Trinity as an AI-powered, insight-driven leader in the sector, ready to address the complex commercialization demands of today’s life sciences organizations.
  • A revitalized digital presence featuring a redesigned website that is simpler to navigate, richer in resources, and offers dynamic thought leadership content aligning with Trinity’s commitment to innovation and transparency within AI-enabled ecosystems.

This brand transformation reaffirms Trinity’s focus on:

  • Delivering integrated, technology-powered solutions that combine our deep therapeutic expertise with actionable analytics.
  • Uniting teams and clients around a modern, forward-focused brand that embodies accountability, innovation, and partnership.
  • Enhancing client acquisition, retention, and loyalty while empowering staff at all levels to be bold, collaborative, and future ready.

About Trinity Life Sciences:
Trinity powers the future of life sciences commercialization through the fusion of human and artificial intelligence. By blending deep therapeutic expertise and trusted human ingenuity with a purpose-built technology platform, Trinity accelerates clarity and confidence at every step of the commercialization journey—from pre-launch to scale to loss of exclusivity. For more than 30 years, the world’s leading pharmaceutical, biotech, and medtech companies have relied on Trinity’s foresight, execution, and partnership to deliver confident product launches, decisive market advantage, and measurable patient impact. For more information, visit Trinity Life Sciences at www.trinitylifesciences.com.

Contacts

Trinity Life Sciences


Release Versions

Contacts

More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom